Moderna President Sells $7.8 Million in Stock as Company Posts Q4 Beat and Advances Flu Vaccine Review
Moderna President Stephen Hoge sold 160,009 shares on February 23, 2026, at $48.84 per share under a Rule 10b5-1 plan, realizing roughly $7.8 million, and exercised options to acquire the same number of shares at $19.15. The moves come while Moderna shares hover near a 52-week high following a substantial six-month rally, and after the company repo…